Skip to main content
. 2024 Jul 3;14(7):716. doi: 10.3390/jpm14070716

Figure 3.

Figure 3

DRR of ixekizumab according to disease duration (a,b), axial disease (c), and skin involvement (d). DRR, drug retention rate.